WHO’s Solidarity trial shows repurposed drugs for Covid-19 are ineffective
World Health Organization (WHO) has reported that interim data from the Solidarity Therapeutics Trial of...
Novartis’ Zolgensma shows therapeutic benefit in SMA patients
Novartis has reported interim data from the ongoing Phase III STR1VE-EU clinical trial of Zolgensma...
Roche’s Evrysdi improves motor functions in infants with SMA
Roche has reported that Evrysdi (risdiplam) lowered the mortality rate in infants aged two to...
Vifor Pharma reports results of Ferinject in AFFIRM-AHF trial
Vifor Pharma has reported data from the AFFIRM-AHF clinical trial of Ferinject (intravenous ferric carboxymaltose)...
AC Immune’s semorinemab misses Alzheimer’s trial goals
Swiss-based biopharmaceutical company AC Immune and Genentech have said that Phase II TAURIEL trial of...
Roche’s Actemra reduces need for mechanised ventilation in Covid-19 patients
Roche has reported that its Actemra/RoActemra (tocilizumab) reduced the need for mechanical ventilation in hospitalised...
Roche begins new clinical trials of multiple sclerosis drugs
Roche has launched a Phase III clinical trial programme of its experimental drug fenebrutinib for...
Roche reports new data of multiple sclerosis drug Ocrevus
Roche has reported new data from analyses of the two-year open-label Phase IIIb CASTING clinical...
Novartis reports inclisiran cut LDL cholesterol in Phase III trials
Novartis has reported positive data from a post-hoc analysis of pooled data from the Phase...
Novartis reports positive data of asciminib in ASCEMBL trial
Novartis has reported positive results from the Phase III ASCEMBL clinical trial of asciminib in...